Osaka, Japan

Shigeyuki Marunaka

USPTO Granted Patents = 5 


 

Average Co-Inventor Count = 3.0

ph-index = 3

Forward Citations = 29(Granted Patents)


Company Filing History:


Years Active: 1997-2015

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Shigeyuki Marunaka: Innovator in Pharmaceutical Technology

Introduction

Shigeyuki Marunaka is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceutical technology, holding a total of 5 patents. His work focuses on improving the printability and effectiveness of solid pharmaceutical preparations.

Latest Patents

Marunaka's latest patents include a method for the treatment of solid pharmaceutical preparations prior to printing. This invention enhances the printability and abrasion resistance of prints on solid dosage forms. The method involves treating the surface of the solid dosage form with a polyethylene glycol-containing aqueous solution before printing. Another notable patent is for a tablet containing a hardly soluble active ingredient, which regulates variation in dissolution from lot to lot. This tablet contains a specific percentage of an active ingredient along with magnesium stearate and hydroxypropylcellulose.

Career Highlights

Throughout his career, Marunaka has worked with prominent companies in the pharmaceutical industry, including Takeda Pharmaceutical Company Limited and Takeda Chemical Industries, Inc. His experience in these organizations has allowed him to develop innovative solutions that address challenges in drug formulation and delivery.

Collaborations

Marunaka has collaborated with several professionals in his field, including Makoto Fukuta and Akihiko Ono. These collaborations have contributed to the advancement of pharmaceutical technologies and the development of new products.

Conclusion

Shigeyuki Marunaka is a distinguished inventor whose work has significantly impacted the pharmaceutical industry. His innovative patents and collaborations demonstrate his commitment to improving drug formulation and delivery methods.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…